OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Resveratrol alleviates motor and cognitive deficits and neuropathology in the A53T α-synuclein mouse model of Parkinson's disease
Lifan Zhang, Xiaolin Yu, Mei Ji, et al.
Food & Function (2018) Vol. 9, Iss. 12, pp. 6414-6426
Closed Access | Times Cited: 103
Lifan Zhang, Xiaolin Yu, Mei Ji, et al.
Food & Function (2018) Vol. 9, Iss. 12, pp. 6414-6426
Closed Access | Times Cited: 103
Showing 1-25 of 103 citing articles:
Aging and age‐related diseases: from mechanisms to therapeutic strategies
Zhe Li, Zhenkun Zhang, Yikun Ren, et al.
Biogerontology (2021) Vol. 22, Iss. 2, pp. 165-187
Open Access | Times Cited: 408
Zhe Li, Zhenkun Zhang, Yikun Ren, et al.
Biogerontology (2021) Vol. 22, Iss. 2, pp. 165-187
Open Access | Times Cited: 408
Gut microbial molecules in behavioural and neurodegenerative conditions
Brittany D. Needham, Rima Kaddurah‐Daouk, Sarkis K. Mazmanian
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 12, pp. 717-731
Closed Access | Times Cited: 273
Brittany D. Needham, Rima Kaddurah‐Daouk, Sarkis K. Mazmanian
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 12, pp. 717-731
Closed Access | Times Cited: 273
Antioxidant Therapy in Oxidative Stress-Induced Neurodegenerative Diseases: Role of Nanoparticle-Based Drug Delivery Systems in Clinical Translation
Anushruti Ashok, Syed Suhail Andrabi, Saffar Mansoor, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 128
Anushruti Ashok, Syed Suhail Andrabi, Saffar Mansoor, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 408-408
Open Access | Times Cited: 128
Tau accelerates α-synuclein aggregation and spreading in Parkinson’s disease
Lina Pan, Chunrui Li, Lanxia Meng, et al.
Brain (2022) Vol. 145, Iss. 10, pp. 3454-3471
Open Access | Times Cited: 78
Lina Pan, Chunrui Li, Lanxia Meng, et al.
Brain (2022) Vol. 145, Iss. 10, pp. 3454-3471
Open Access | Times Cited: 78
Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson’s disease: an overview and update on new developments
Mohammad Yasin Zamanian, Rosario Mireya Romero‐Parra, Afsaneh Soltani, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 6, pp. 5455-5464
Closed Access | Times Cited: 44
Mohammad Yasin Zamanian, Rosario Mireya Romero‐Parra, Afsaneh Soltani, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 6, pp. 5455-5464
Closed Access | Times Cited: 44
Oxidative Stress in Parkinson’s Disease: Potential Benefits of Antioxidant Supplementation
Sandro Percário, Aline da Silva Barbosa, Everton Luiz Pompeu Varela, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-23
Open Access | Times Cited: 116
Sandro Percário, Aline da Silva Barbosa, Everton Luiz Pompeu Varela, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-23
Open Access | Times Cited: 116
Recent advances in extracting phenolic compounds from food and their use in disease prevention and as cosmetics
Ricardo Dias, Hélder Oliveira, Iva Fernandes, et al.
Critical Reviews in Food Science and Nutrition (2020) Vol. 61, Iss. 7, pp. 1130-1151
Closed Access | Times Cited: 110
Ricardo Dias, Hélder Oliveira, Iva Fernandes, et al.
Critical Reviews in Food Science and Nutrition (2020) Vol. 61, Iss. 7, pp. 1130-1151
Closed Access | Times Cited: 110
Dietary Plant Polyphenols as the Potential Drugs in Neurodegenerative Diseases: Current Evidence, Advances, and Opportunities
Lu Yan, Min‐Song Guo, Yue Zhang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-40
Open Access | Times Cited: 59
Lu Yan, Min‐Song Guo, Yue Zhang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-40
Open Access | Times Cited: 59
Neuroprotective Effects of Resveratrol in In vivo and In vitro Experimental Models of Parkinson’s Disease: a Systematic Review
Michele Goulart dos Santos, Lúcia Emanueli Schimith, Corinne André‐Miral, et al.
Neurotoxicity Research (2022) Vol. 40, Iss. 1, pp. 319-345
Closed Access | Times Cited: 48
Michele Goulart dos Santos, Lúcia Emanueli Schimith, Corinne André‐Miral, et al.
Neurotoxicity Research (2022) Vol. 40, Iss. 1, pp. 319-345
Closed Access | Times Cited: 48
Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
Jihoon Lee, Ki Woon Sung, Eun-Jin Bae, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 34
Jihoon Lee, Ki Woon Sung, Eun-Jin Bae, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 34
Gut Microbiota and its Metabolites: Bridge of Dietary Nutrients and Alzheimer’s Disease
Guangsu Zhu, Jianxin Zhao, Hao Zhang, et al.
Advances in Nutrition (2023) Vol. 14, Iss. 4, pp. 819-839
Open Access | Times Cited: 28
Guangsu Zhu, Jianxin Zhao, Hao Zhang, et al.
Advances in Nutrition (2023) Vol. 14, Iss. 4, pp. 819-839
Open Access | Times Cited: 28
DNA Damage-Mediated Neurotoxicity in Parkinson’s Disease
Zhong‐Xuan Wang, Yaolin Li, Jiali Pu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6313-6313
Open Access | Times Cited: 22
Zhong‐Xuan Wang, Yaolin Li, Jiali Pu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6313-6313
Open Access | Times Cited: 22
Progress in the Treatment of Central Nervous System Diseases Based on Nanosized Traditional Chinese Medicine
Jing Li, Qingyin Long, Huang Ding, et al.
Advanced Science (2024) Vol. 11, Iss. 16
Open Access | Times Cited: 12
Jing Li, Qingyin Long, Huang Ding, et al.
Advanced Science (2024) Vol. 11, Iss. 16
Open Access | Times Cited: 12
Therapeutic potential of stilbenes in neuropsychiatric and neurological disorders: A comprehensive review of preclinical and clinical evidence
Katarzyna Socała, Elżbieta Żmudzka, Klaudia Lustyk, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 3, pp. 1400-1461
Closed Access | Times Cited: 11
Katarzyna Socała, Elżbieta Żmudzka, Klaudia Lustyk, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 3, pp. 1400-1461
Closed Access | Times Cited: 11
SIRT1 Regulation in Ageing and Obesity
Patricia S. Pardo, Aladin M. Boriek
Mechanisms of Ageing and Development (2020) Vol. 188, pp. 111249-111249
Open Access | Times Cited: 67
Patricia S. Pardo, Aladin M. Boriek
Mechanisms of Ageing and Development (2020) Vol. 188, pp. 111249-111249
Open Access | Times Cited: 67
Role of Flavonoids in Neurodegenerative Diseases: Limitations and Future Perspectives
Gagandeep Maan, Biplab Sikdar, Ashish Kumar, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 13, pp. 1169-1194
Closed Access | Times Cited: 66
Gagandeep Maan, Biplab Sikdar, Ashish Kumar, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 13, pp. 1169-1194
Closed Access | Times Cited: 66
Promising Polyphenols in Parkinson’s Disease Therapeutics
Ashish Singh, Pratibha Tripathi, Arun Kumar Yadawa, et al.
Neurochemical Research (2020) Vol. 45, Iss. 8, pp. 1731-1745
Closed Access | Times Cited: 63
Ashish Singh, Pratibha Tripathi, Arun Kumar Yadawa, et al.
Neurochemical Research (2020) Vol. 45, Iss. 8, pp. 1731-1745
Closed Access | Times Cited: 63
Phytochemicals Bridging Autophagy Induction and Alpha-Synuclein Degradation in Parkinsonism
Fiona Limanaqi, Francesca Biagioni, Carla L. Busceti, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3274-3274
Open Access | Times Cited: 62
Fiona Limanaqi, Francesca Biagioni, Carla L. Busceti, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3274-3274
Open Access | Times Cited: 62
The Stemness of Human Ovarian Granulosa Cells and the Role of Resveratrol in the Differentiation of MSCs—A Review Based on Cellular and Molecular Knowledge
Małgorzata Józkowiak, Greg Hutchings, Maurycy Jankowski, et al.
Cells (2020) Vol. 9, Iss. 6, pp. 1418-1418
Open Access | Times Cited: 61
Małgorzata Józkowiak, Greg Hutchings, Maurycy Jankowski, et al.
Cells (2020) Vol. 9, Iss. 6, pp. 1418-1418
Open Access | Times Cited: 61
Resveratrol induces depletion of TRAF6 and suppresses prostate cancer cell proliferation and migration
Farjana Yeasmin Khusbu, Xi Zhou, Mridul Roy, et al.
The International Journal of Biochemistry & Cell Biology (2019) Vol. 118, pp. 105644-105644
Closed Access | Times Cited: 59
Farjana Yeasmin Khusbu, Xi Zhou, Mridul Roy, et al.
The International Journal of Biochemistry & Cell Biology (2019) Vol. 118, pp. 105644-105644
Closed Access | Times Cited: 59
Resveratrol in Rodent Models of Parkinson’s Disease: A Systematic Review of Experimental Studies
Cheng-Fu Su, Jiang Li, Xiaowen Zhang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 54
Cheng-Fu Su, Jiang Li, Xiaowen Zhang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 54
C-Phycocyanin-derived Phycocyanobilin as a Potential Nutraceutical Approach for Major Neurodegenerative Disorders and COVID-19- induced Damage to the Nervous System
Giselle Pentón‐Rol, Javier Marín‐Prida, Mark F. McCarty
Current Neuropharmacology (2021) Vol. 19, Iss. 12, pp. 2250-2275
Open Access | Times Cited: 43
Giselle Pentón‐Rol, Javier Marín‐Prida, Mark F. McCarty
Current Neuropharmacology (2021) Vol. 19, Iss. 12, pp. 2250-2275
Open Access | Times Cited: 43
The potential applications of traditional Chinese medicine in Parkinson's disease: A new opportunity
Jiaxue Chen, Jingke Xu, Ping Huang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112866-112866
Open Access | Times Cited: 29
Jiaxue Chen, Jingke Xu, Ping Huang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 149, pp. 112866-112866
Open Access | Times Cited: 29
Antiplatelet drugs: Potential therapeutic options for the management of neurodegenerative diseases
Samir Kumar Beura, Rishika Dhapola, Abhishek Panigrahi, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 6, pp. 1835-1877
Closed Access | Times Cited: 20
Samir Kumar Beura, Rishika Dhapola, Abhishek Panigrahi, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 6, pp. 1835-1877
Closed Access | Times Cited: 20
Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?
Viviana Brembati, Gaia Faustini, Francesca Longhena, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 18
Viviana Brembati, Gaia Faustini, Francesca Longhena, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 18
